Biorelevant characterization system for subcutaneous injections

Combined Synopsis/Solicitation from Food and Drug Administration, solicitation 75F401F25R00066. Responses due May 9, 2025. NAICS 334516, Small Business Set Aside - Total. Listed on SAM.gov.